Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
Nature Communications
|
December 10, 2020
Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis
Rowena A Bull, Thiruni N Adikari, James M Ferguson, et al.
Mabs
|
May 24, 2021
Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
Romain Rouet, Ohan Mazigi, Gregory J Walker, et al.
Scientific Reports
|
October 24, 2020
Single molecule, near full-length genome sequencing of dengue virus
Thiruni N Adikari, Nasir Riaz, Chathurani Sigera, et al.
Viruses
|
February 9, 2021
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
Gregory J Walker, Zin Naing, Alberto Ospina Stella, et al.
Journal of Viral Hepatitis
|
December 23, 2018
Genomic variability of within-host hepatitis C variants in acute infection
Chaturaka Rodrigo, Preston Leung, Andrew R Lloyd, et al.
Scientific Reports
|
February 17, 2021
Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing
Ki Wook Kim, Ira W Deveson, Chi Nam I Pang, et al.
Nature Communications
|
December 8, 2022
Identification of human progenitors of exhausted CD8<sup>+</sup> T cells associated with elevated IFN-γ response in early phase of viral infection
Curtis Cai, Jerome Samir, Mehdi R Pirozyan, et al.
Journal of Medical Virology
|
May 5, 2022
Persistent high-level shedding of cultivable SARS-CoV-2 Delta virus 33 days after onset of COVID-19 in a hospitalized patient with pneumonia
Ki Wook Kim, Xinye Wang, Anurag Adhikari, et al.
Clinical & Translational Immunology
|
August 30, 2023
A unique cytotoxic CD4<sup>+</sup> T cell-signature defines critical COVID-19
Sarah Baird, Caroline L Ashley, Felix Marsh-Wakefield, et al.
The International Journal on Drug Policy
|
March 20, 2026
Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study
Anna Conway, Jason Grebely, Shane Tillakeratne, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
Nature Communications
|
December 10, 2020
Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis
Rowena A Bull, Thiruni N Adikari, James M Ferguson, et al.
Mabs
|
May 24, 2021
Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
Romain Rouet, Ohan Mazigi, Gregory J Walker, et al.
Scientific Reports
|
October 24, 2020
Single molecule, near full-length genome sequencing of dengue virus
Thiruni N Adikari, Nasir Riaz, Chathurani Sigera, et al.
Viruses
|
February 9, 2021
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
Gregory J Walker, Zin Naing, Alberto Ospina Stella, et al.
Journal of Viral Hepatitis
|
December 23, 2018
Genomic variability of within-host hepatitis C variants in acute infection
Chaturaka Rodrigo, Preston Leung, Andrew R Lloyd, et al.
Scientific Reports
|
February 17, 2021
Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing
Ki Wook Kim, Ira W Deveson, Chi Nam I Pang, et al.
Nature Communications
|
December 8, 2022
Identification of human progenitors of exhausted CD8<sup>+</sup> T cells associated with elevated IFN-γ response in early phase of viral infection
Curtis Cai, Jerome Samir, Mehdi R Pirozyan, et al.
Journal of Medical Virology
|
May 5, 2022
Persistent high-level shedding of cultivable SARS-CoV-2 Delta virus 33 days after onset of COVID-19 in a hospitalized patient with pneumonia
Ki Wook Kim, Xinye Wang, Anurag Adhikari, et al.
Clinical & Translational Immunology
|
August 30, 2023
A unique cytotoxic CD4<sup>+</sup> T cell-signature defines critical COVID-19
Sarah Baird, Caroline L Ashley, Felix Marsh-Wakefield, et al.
The International Journal on Drug Policy
|
March 20, 2026
Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study
Anna Conway, Jason Grebely, Shane Tillakeratne, et al.
Page
of 12